Bayer recently received FDA approval for a connected auto-injector for relapsing-remitting multiple sclerosis medication and companion app. The device is called the Betaconnect Electronic Autoinjector ...
LONDON--(BUSINESS WIRE)--Technavio has been monitoring the global contrast injectors market since 2015 and the market is poised to grow by USD 613.47 million during 2020-2024, progressing at a CAGR of ...
How do you keep a 22-year-old injectable multiple sclerosis therapy competitive in the face of threats from high-flying oral contenders? Bayer has an idea. The company recently won FDA approval for ...
WHIPPANY, N.J., Sept. 25, 2015 /PRNewswire/ -- Bayer HealthCare announced today that the U.S. Food and Drug Administration (FDA) approved BETACONNECT, the first and only electronic autoinjector in the ...
DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "United States Contrast Media Injectors Market Outlook to 2022" report to their offering. The report provides value, in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback